Answers are grounded in this paper and cite their sources.
Benjamin Franklin famously wrote, “An ounce of prevention is worth a pound of cure.” This statement is considered axiomatic when pediatric obesity is the subject. Those who develop obesity during childhood acquire increased risks for later morbidity and mortality (1), independent of their adult body mass (2). In addition to the manifold obesity-related cardiovascular and metabolic disorders that may arise at any age and are increasingly common among children, there are unique consequences of early-onset obesity that are not reversible by subsequent weight reduction (3). We are all united in believing that obesity prevention should be our goal; what has held back progress has been the dearth of strategies with clearly demonstrated efficacy for the prevention of pediatric obesity (4,5). In the February 2011 issue of Obesity, Paul et al. (6) present pilot data for a bold and innovative approach to the prevention of undue weight gain in infancy. The authors tested the effects of two complementary interventions initiated 2–3 weeks after birth. First, based on the epidemiologic data suggesting that children who sleep fewer hours at night tend to have greater weight gain than those with an average sleep duration, they reasoned that a program that successfully promoted longer overnight infant sleep might diminish subsequent weight gain. Their sleep-lengthening program involved teaching parents nonfeeding approaches to addressing infants’ fussiness, so that offering energy intake would not be the first strategy used. Second, based on the notions that solid foods are often introduced earlier than recommended and that older infants consuming a diet that contains more vegetables and other healthful foods should gain less weight, they studied the effects of teaching mothers about hunger and satiety cues, the appropriate age at which to introduce foods, and ways to overcome neophobia when introducing vegetables (which are often initially rejected by infants). A total of 160 mother–infant dyads, with mothers who planned to breast-feed, were enrolled and randomized using a 2 × 2 design such that approximately 40 dyads received either no intervention, each of the interventions alone, or both interventions together. The results were quite striking. Among the 110 infants with data collected at age 1 year, coadministration of the two interventions had a significant effect on weight-for-length gain, whereas administration of either intervention alone was associated with no difference vs. the control condition. The double-intervention group had a mean weight for length at the 33rd percentile, while the other three groups had mean weight for length at the 50th to 56th percentiles. These results were confirmed with a last-observation-carried-forward approach for those with at least some follow-up data. Subanalyses suggested that the interventions were particularly effective among infants who continued to be predominantly breast-fed but might be less so for infants who were no longer being mostly breast-fed at 16 weeks of age. Notwithstanding these groundbreaking results, there are some limitations of this study that must be carefully considered. First, the components of the primary outcome – weight for length – were measured by study nurses who were aware of group assignments. It is thus conceivable that the results obtained were, to some extent, affected by unconscious biases, given the known difficulties in measuring supine length in infants (7) and the known effects of being unblinded on height-measurement error (8). Second, there are some statistical concerns, among which is the use of data obtained after the interventions were initiated as covariates in models – for example, the number of feedings reported at 16 weeks, which might plausibly be expected to be altered in some of the intervention groups, was a covariate for the main study outcome, weight for length at 1 year of age. Third, the group receiving both interventions had a large dropout rate, which suggests that subject burden was high for those taking part in both interventions. Although much of the burden may have been due to the assessments carried out rather than from the interventions themselves, feasibility of the double intervention needs to be tested in a broad spectrum of mother–infant dyads, including in those of lower socioeconomic status, among whom obesity is more prevalent and intensive interventions may be particularly challenging to implement. Fourth, the article reports results of a pilot study, and because the small sample size makes it impossible to analyze results separately for infants who had overweight/obese parents, it is unknown whether the program had beneficial effects among those believed to be at greatest risk for excessive weight gain. Finally, for infants unselected for risk of obesity, it is by no means certain that achieving a mean weight for length at the 33rd percentile is an improvement over the control condition in which the mean weight for length was at the 50th percentile. Some might argue the contrary – that there is at least a potential for possible harm when an intervention diminishes growth in otherwise normal infants. These innovative interventions need to be critically tested in future studies that enroll families whose children are anticipated to be particularly at risk for later obesity and that are adequately powered to identify potential adverse events. Paul et al. (6) are to be congratulated for carrying out an extremely creative, groundbreaking study that is truly hypothesis-generating. If the results can be replicated on a larger scale, this study may prove to be an extremely important development for pediatric obesity-prevention efforts. Rather than representing an incremental improvement of prior attempts to prevent pediatric obesity, most of which have focused on school-aged children, it boldly tackles the issue in the first months of life. The study thus opens up a new and exciting area of future research and potential translation. It is fervently hoped that randomized controlled trials that test these interventions on a much larger scale will prove to be as positive. The author received support from the NIH Intramural Research Program, grant Z01-HD-00641 from the NICHD. Dr. Yanovski is a Commissioned Officer in the United States Public Health Service, DHHS. The author declared no conflict of interest.
No takes yet. Share an insight, caveat, or question.
Jack A. Yanovski (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: